ProCE Banner Activity

Managing Acute and Long-term Toxicities With CAR T-Cell Products


Review strategies for managing acute and long-term adverse events related to CAR T-cell therapies for multiple myeloma with these downloadable slides from an expert webinar.

Released: February 22, 2023

Expiration: February 21, 2024

Begin Activity



Amrita Krishnan

Amrita Krishnan, MD, FACP

Director, Judy and Bernard Briskin Center for Multiple Myeloma Research
City of Hope
Duarte, California

Provided by

ProCE Banner


Supported by educational grants from

Bristol Myers Squibb

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC